A detailed history of Bollard Group LLC transactions in Viatris Inc stock. As of the latest transaction made, Bollard Group LLC holds 51 shares of VTRS stock, worth $663. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51
Previous 51 -0.0%
Holding current value
$663
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $10 - $12
1 Added 2.0%
51 $1,000
Q4 2023

Feb 13, 2024

SELL
$8.77 - $10.85 $543 - $672
-62 Reduced 55.36%
50 $1,000
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $1,400 - $1,657
-146 Reduced 56.59%
112 $1,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $9 - $10
1 Added 0.39%
258 $3,000
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $10,294 - $13,718
-1,119 Reduced 81.32%
257 $2,000
Q4 2022

Feb 10, 2023

BUY
$8.72 - $11.56 $43 - $57
5 Added 0.36%
1,376 $15,000
Q3 2022

Nov 09, 2022

BUY
$8.48 - $11.13 $50 - $66
6 Added 0.44%
1,371 $12,000
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $23,193 - $28,601
-2,331 Reduced 63.07%
1,365 $14,000
Q1 2022

May 12, 2022

SELL
$9.81 - $15.4 $50,129 - $78,694
-5,110 Reduced 58.03%
3,696 $40,000
Q4 2021

Feb 11, 2022

SELL
$12.09 - $14.68 $1,039 - $1,262
-86 Reduced 0.97%
8,806 $119,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $6,187 - $7,065
-467 Reduced 4.99%
8,892 $120,000
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $6,692 - $8,333
-516 Reduced 5.23%
9,359 $134,000
Q4 2020

Feb 04, 2021

BUY
$14.3 - $18.74 $141,212 - $185,057
9,875 New
9,875 $185,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.